VP, Head of Market Access

VP, Head of Market Access

Los Angeles / Hybrid

Our 3 Core Values

• Intelligence

• Integrity

• Initiative

Our mission is to harness the immune system through innovative cell therapies and other modalities to deliver widely accessible cures. Patients are waiting

What You'll Do:

Reporting to the Chief Commercial Officer, the
VP, Head of Market Access
will lead Immix Biopharma's market access strategy and execution for its lead asset, NXC-201 and the company's future portfolio. This is a critical senior leadership role that will be instrumental in the Company's continued success.

What We Look For:

Job Requirements

• Responsible for all aspects of Market Access including market access strategy, pricing, patient access & reimbursement services, channel strategy, field-based account management, market access operations, and contracting.
• Ensure Market Access team is working effectively with cross-functional partners in Commercial Operations, Medical Affairs, Marketing, Training, and Sales to maintain strategic alignment, produce high quality deliverables, and achieve performance objectives.
• Must have the ability to develop a strong understanding of the AL Amyloidosis/CAR-T market and be able to build a market access strategy to support both current and future products as the pipeline matures.
• Lead, motivate, develop, and retain a team of highly skilled market access professionals.
• Responsible for Immix Biopharma's strategic and tactical plans to ensure optimal patient access across all payer types including commercial payers, PBMs/OBMs, Medicaid, Medicare, and federal VA/DOD channels.
• Partner with Sales leadership to understand customer needs, enhance the customer experience, and build partnerships with key customers while optimizing overall impact to the business.
• Partner with the commercial operations to envision, design, and implement the channel based data flows (e.g., specialty pharmacy and specialty distributor data, patient support center data, etc.) necessary to understand the business, track key trends and performance metrics, and identify opportunities for continued improvement.
• Partner with commercial leadership team to develop and execute optimized pricing and contracting strategies, monitor impact, and recommend ways to continually improve over time.
• Partner with Marketing & HEOR/Medical Affairs leadership to develop product value propositions, evidence generation plans, messaging, and supporting economic analyses/models.
• Oversee a high-performing field-based account management team responsible for a broad spectrum of critical relationships including commercial and government payers, specialty pharmacies, GPOs, key provider accounts, etc.
• Execute channel strategies to ensure effective and efficient delivery of products to end users. Maintain close oversight of all aspects of channel operations and performance management including inventory management.
• Work closely with Finance, Legal and Commercial Operations teams to map data strategy and ensure key data contracts are in place with channel partners to enable sales tracking, revenue recognition, government price reporting, and rebate adjudication and payment
• Oversee execution of key patient access & reimbursement programs to optimize patient access and affordability while optimizing commercial results.
• Establish relationships and facilitate activities across various industry segments (providers, patients, payers, specialty pharmacies, distributors, internal hub team) to ensure effective and efficient patient access, product delivery, and financial flows.
• Keep company informed and ready for the rapidly changing market access environment (e.g., Medicare payment reforms, pricing policies) to inform corporate strategy, portfolio strategy, product forecasts, and long-term plans.
• Work closely with compliance to ensure adherence to relevant laws and regulations.
• Work closely with Commercial Training & Effectiveness to ensure entire commercial organization is well trained on key market access topics and programs and highly effective at communicating and implementing them with customers.
• Provide thought leadership on access issues related to pipeline products
• Partner and ensure regular, effective communication with marketing and sales leadership to identify challenges and opportunities and deliver solutions as needed
• Participate on product strategy teams to inform portfolio planning with critical global market access insights
• Other duties as assigned

Education & Experience

• Bachelor's degree required, MBA
  preferred.
• 15+ years of experience within biotech/pharmaceuticals, with recent focus in market access leadership.
• 10+ years leadership in market access with previous direct experience in relevant functions (e.g., channel/distribution, payer management, patient services, etc.).

Knowledge, Skills & Abilities

• Proven expert in leading and developing market access functions
• Launch experience for
  rare indications, oncology, and CAR-T
  experience
  preferred.
• Experience building teams and commercial capabilities is required.
• Existing relationships with key customers are highly valued (e.g., KOLs, key account leadership, oncology societies, GPOs, etc.)
• Must be a true team player – authentic, humble, able to build a positive team spirit and lead through the ups and downs of drug development, puts success of team above own interests and support everyone's efforts to grow and develop
• Demonstrated ability to motivate and lead teams and have the managerial courage to make and stand by difficult decisions
• Experience in and understanding of other commercial functions (e.g., marketing, commercial operations, sales operations, sales training, insights/analytics, business development, etc.) will be an important consideration for this role.
• Must be highly analytical. Must be comfortable formulating and delivering data-driven, fact based analyses of the business and utilizing these insights to propose effective strategies to meet corporate objectives.
• Must be a resourceful, creative problem solver who seeks out, and is receptive to, new ideas and approaches to solving persistent challenges.
• Ability and willingness to work effectively and seamlessly at multiple "altitudes" within the organization. Maintains a "no job is too big or too small" attitude necessary to succeed in a startup environment.
• Excellent interpersonal, oral and written communication skills (including ability to successfully convey insights and recommendations via PowerPoint), including ability to synthesize data and deliver a clear overview of the state of the business, drivers of performance, opportunities and risks, and recommended action plans. Strong executive presence and comfortable presenting to C-Suite and board of directors.
• Demonstrated ability to attract top talent with diverse backgrounds and build cohesive, high performing teams
• Demonstrated ability to adapt to changes in the work environment. Manages competing demands. Changes approach or method to best fit the situation. Able to deal with frequent change, delays, unexpected events, or uncertainty/ambiguity with maturity and professionalism.
• Highly skilled in influencing cross-functional teams, including interfacing with key internal and external stakeholders and with scientific and commercial teams

About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a global leader in relapsed/refractory AL Amyloidosis. AL Amyloidosis is a devastating disease where the immune system, that's supposed to protect, instead produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a "digital filter" that is designed to filter out non-specific activation. NXC-201 teaches the immune system to recognize and eliminate the source of the toxic light chains. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT , with a registrational design. NXC-201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA. Learn more at and